Financial Performance - The company's operating revenue for Q1 2025 was CNY 311,046,902.64, representing a year-on-year increase of 9.58% compared to CNY 283,856,179.34 in the same period last year[3]. - The net profit attributable to shareholders was CNY 55,106,577.26, a slight increase of 0.91% from CNY 54,609,256.13 in the previous year[3]. - The net profit after deducting non-recurring gains and losses was CNY 53,680,039.51, showing a decrease of 0.93% compared to CNY 54,184,637.68 last year[3]. - The basic and diluted earnings per share were both CNY 0.50, reflecting a 2.04% increase from CNY 0.49 in the same period last year[3]. - The overall gross margin decreased by 1.56 percentage points year-over-year, primarily due to the trial production efforts of the Vietnam subsidiary, which did not yield significant output during the period[12]. - Operating profit for Q1 2025 was CNY 64,593,615.73, slightly up from CNY 64,300,975.00 in Q1 2024[18]. - Net profit for Q1 2025 was CNY 53,039,599.02, a decrease of 1.3% from CNY 53,752,439.62 in Q1 2024[18]. - The total comprehensive income for the first quarter of 2025 was CNY 64,439,651.55, compared to CNY 55,369,754.50 in the first quarter of 2024, representing an increase of approximately 12.5%[32]. Cash Flow - The company's cash flow from operating activities was CNY 80,819,986.95, down by 2.47% from CNY 82,864,182.96 in the same period last year[3]. - Cash inflows from operating activities amounted to CNY 364,624,692.55 in Q1 2025, up from CNY 312,253,875.44 in Q1 2024, reflecting a growth of about 16.7%[32]. - The net cash flow from operating activities decreased to CNY 94,945,139.72 in Q1 2025, down from CNY 114,678,539.03 in Q1 2024, indicating a decline of approximately 17.2%[32]. - Cash outflows from investment activities totaled CNY 340,338,051.87 in Q1 2025, significantly higher than CNY 12,411,664.29 in Q1 2024, marking an increase of over 2,640%[33]. - The net cash flow from investment activities was negative at CNY -109,323,648.45 in Q1 2025, compared to a positive CNY 5,479,656.26 in Q1 2024[33]. - The ending balance of cash and cash equivalents was CNY 142,700,008.19 as of the end of Q1 2025, down from CNY 341,060,168.87 at the end of Q1 2024, a decrease of approximately 58%[33]. - Cash received from tax refunds in Q1 2025 was CNY 7,964,068.13, compared to CNY 1,300,499.47 in Q1 2024, showing an increase of approximately 513%[32]. - The company paid CNY 203,600,127.96 for goods and services in Q1 2025, which is an increase from CNY 133,655,499.72 in Q1 2024, reflecting a growth of about 52.3%[32]. Research and Development - Research and development expenses totaled CNY 26,627,960.33, an increase of 18.51% from CNY 22,468,887.93 in the previous year, accounting for 8.56% of operating revenue[3][4]. - Research and development expenses reached RMB 26.628 million, reflecting an 18.51% increase year-over-year, while marketing expenses totaled RMB 27.372 million, up 10.35% year-over-year, significantly impacting net profit[12]. - Research and development expenses for Q1 2025 were ¥21,244,649.19, an increase of 13.6% compared to ¥18,680,717.67 in Q1 2024[31]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,719,700,052.85, a slight increase of 0.86% from CNY 1,705,033,147.02 at the end of the previous year[4]. - Current assets totaled RMB 892.9 million, showing an increase from RMB 876.8 million at the end of 2024[13]. - The company’s total liabilities were RMB 892.9 million, with current liabilities at RMB 192.4 million, down from RMB 243.2 million at the end of 2024[14]. - Total liabilities decreased to CNY 432,085,225.78 in 2025 from CNY 472,123,057.30 in 2024, reflecting a reduction of approximately 8.5%[15]. - The total equity attributable to shareholders increased to CNY 1,289,520,183.94 in 2025 from CNY 1,235,102,023.58 in 2024, marking a growth of about 4.4%[15]. - The total equity as of March 31, 2025, was ¥1,295,710,055.84, an increase of 5.4% from ¥1,229,086,954.51 at the end of 2024[28]. Shareholder Information - The company’s actual controller holds a voting power ratio of 57.45% through various partnerships and entities[11]. - The top ten shareholders collectively hold significant stakes, with the largest shareholder, Youlide Group, owning 60,222,200 shares[11].

长城证券股份有限公司 关于优利德科技（中国）股份有限公司 首次公开发行股票并在科创板上市之保荐总结报告书 长城证券股份有限公司（以下简称"长城证券"或"保荐机构"）作为优利 德科技（中国）股份有限公司（以下简称"优利德"、"上市公司"、"发行人" 或"公司"）首次公开发行股票并在科创板上市的保荐机构，根据《证券发行上 市保荐业务管理办法》《上海证券交易所科创板股票上市规则》《上海证券交易 所科创板上市公司自律监管指引第 1 号——规范运作》等相关规定，长城证券对 优利德的持续督导时间为发行人上市当年及其后 3 个完整的会计年度，优利德于 2021 年 2 月 1 日起在上海证券交易所挂牌上市，持续督导期为 2021 年 2 月 1 日 至 2024 年 12 月 31 日。现长城证券对优利德的持续督导期限已满，长城证券根 据相关法律法规，出具本保荐总结报告。 一、保荐机构及保荐代表人承诺 1、保荐总结报告书和证明文件及其相关资料的内容不存在虚假记载、误导 性陈述或重大遗漏，保荐机构及保荐代表人对其真实性、准确性、完整性承担法 律责任。 2、本机构及本人自愿接受中国证券监督管理委员会（以下简称"中国证监 会"） ...

2024 年度持续督导跟踪报告 根据《证券发行上市保荐业务管理办法》《上海证券交易所科创板股票上市 规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等 有关法律、法规的规定，长城证券股份有限公司（以下简称"长城证券"、"保 荐机构"）作为优利德科技（中国）股份有限公司（以下简称 "优利德"、"公 司"）持续督导工作的保荐机构，负责优利德上市后的持续督导工作，并出具本 持股督导跟踪报告。 一、持续督导工作情况 | 序号 | 工作内容 | 持续督导情况 | | --- | --- | --- | | 1 | 建立健全并有效执行持续督导工作制度，并 针对具体的持续督导工作制定相应的工作 | 保荐机构已建立健全并有效执行了持 | | | | 续督导制度，并制定了相应的工作计划 | | | 计划 | | | | 根据中国证监会相关规定，在持续督导工作 开始前，与上市公司或相关当事人签署持续 | 保荐机构已与优利德签订《保荐协议》， | | 2 | 督导协议，明确双方在持续督导期间的权利 | 该协议明确了双方在持续督导期间的 | | | | 权利和义务，并报上海证券交易所备案 | | | 义务，并 ...

长城证券股份有限公司 关于优利德科技（中国）股份有限公司 2024 年度持续督导现场检查报告 长城证券股份有限公司（以下简称"长城证券"、"保荐机构"）作为优利 德科技（中国）股份有限公司（以下简称"优利德"、"公司"）首次公开发行 股票并在科创板上市的保荐机构，根据《证券发行上市保荐业务管理办法》（以 下简称"《保荐办法》"）以及《上海证券交易所科创板上市公司自律监管指引 第 1 号——规范运作》等相关法规规定，于 2025 年 4 月 15 日及 21 日对优利德 进行了现场检查。现将本次现场检查情况报告如下： （四）现场检查人员 保荐代表人张涛、项目组成员杨虎 （五）现场检查内容 一、本次现场检查的基本情况 （一）持续督导机构 长城证券股份有限公司 （二）保荐代表人 张涛、漆传金 （三）现场检查时间 2025 年 4 月 15 日、4 月 21 日 6、核查本持续督导期间公司发生的关联交易、对外担保和对外投资情况。 二、募集资金投资项目的基本情况 （一）公司治理和内部控制状况 现场检查人员核查了公司最新的公司章程，核查了公司股东大会、董事会、 监事会和独立董事意见等资料，并查阅了公司相关内控制度。 公司 ...

从行业市盈率排名来看，公司所处的仪器仪表行业市盈率平均74.38倍，行业中值49.53倍，优利德排名 第20位。 截至2025年一季报，共有18家机构持仓优利德，其中基金13家、其他5家，合计持股数7301.62万股，持 股市值28.01亿元。 4月24日，优利德今日收盘37.12元，上涨1.39%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到22.52倍，创16天以来新低，总市值41.31亿元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)20优利德22.5222.523.2041.31亿行业平均 74.3872.384.4845.07亿行业中值49.5350.453.1032.67亿1先锋电子-297.8791.112.8824.12亿2恒合股 份-172.28-155.935.7415.14亿3莱赛激光-160.64-160.643.9314.02亿4禾信仪器-122.66-122.6614.6856.41亿5 东方中科-120.39-86.021.8073.19亿6宏英智能-74.77-237.292.3822.88亿7安控科技-40.14-43.387.6140.86亿8 ...

| 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.5000 | 0.4900 | 2.04 | 0.3700 | | 每股净资产（元） | 11.59 | 11.18 | 3.67 | 9.98 | | 每股公积金(元) | 5.46 | 5.38 | 1.49 | 5.27 | | 每股未分配利润(元) | 4.76 | 4.32 | 10.19 | 3.29 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 3.11 | 2.84 | 9.51 | 2.38 | | 净利润(亿元) | 0.55 | 0.55 | 0 | 0.41 | | 净资产收益率(%) | 4.36 | 4.51 | -3.33 | 3.77 | 一、主要会计数据和财务指标 本次公司不分配不转赠。 数据四舍五入，查看更多财务数据>> | 名称 | 持有数量(万股) | 占总股本比例(%) | 增减情况(万股) | | --- | --- ...

优利德公告，2025年第一季度营收为3.11亿元，同比增长9.58%；净利润为5510.66万元，同比增长 0.91%。 ...

Core Viewpoint - The company reported steady growth in revenue and profit for 2024, with significant improvements in gross margin and R&D investment [2][4]. Financial Performance - In 2024, the company achieved revenue of 1.13 billion, a year-on-year increase of 10.8% [2] - The net profit attributable to shareholders reached 183 million, reflecting a year-on-year growth of 13.6% [2] - The gross margin for 2024 was 45.16%, up 1.8 percentage points from 2023, driven by improved product structure and enhanced competitiveness [2] R&D Investment - The company maintained a high level of R&D investment, with annual R&D expenses amounting to 117 million, representing a historical high R&D expense ratio of 10.4% [2] - The core team expanded to over 300 personnel, with continuous breakthroughs in patent technology [2] Product Development - Testing instrument revenue exceeded 150 million in 2024, showing a year-on-year growth of 14.6% despite pressure on downstream demand [3] - The company accelerated the development of testing instruments, launching new high-bandwidth products and enhancing product variety in signal sources and spectrum analyzers [3] Competitive Advantage - The company has a diverse product range in the instrumentation sector, providing a high safety margin for performance [4] - The gradual high-end transformation of instruments and breakthroughs in key components are expected to drive future growth [4] Growth Targets - The company announced a stock incentive plan, aiming for a compound annual profit growth rate of 20% from 2024 to 2026, with stable growth targets for testing instruments and specialized instruments [4] Investment Outlook - Based on the latest performance report, revenue forecasts for 2025 and 2026 have been adjusted slightly upward, with expected revenues of 1.31 billion and 1.49 billion respectively [5] - The net profit forecasts for the same years have been adjusted to 240 million and 290 million respectively, with an estimated EPS of 2.13 and 2.58 [5] - For 2027, the company is projected to achieve revenue of 1.7 billion and a net profit of 350 million, with an EPS of 3.14 [5]

Investment Rating - The report maintains an "Outperform" rating for the machinery equipment industry [5]. Core Views - The humanoid robot sector is rapidly advancing, with Tesla's humanoid robot aiming for mass production of 5,000 units by 2025. Domestic companies like Yushutech and ZhiYuan Robotics are also innovating quickly, focusing on key components such as reducers and sensors [3][4]. - AI infrastructure is experiencing growth driven by demand for data centers, benefiting companies involved in cooling systems [4]. - The low-altitude economy is progressing with infrastructure initiatives, aiming to create a unified air traffic management network [4]. Industry Dynamics - Humanoid Robots: Recent demonstrations include the release of a dexterous hand technology by Xingdong Era and a boxing video by Yushutech [1][18]. - Smart Welding: The application of pipeline welding robots by China National Petroleum has achieved scale [20]. - Low-altitude Economy: New companies and initiatives are being established to support the development of low-altitude economic infrastructure [21][26]. Company Dynamics - Yushutech and Chang'an Automobile signed a strategic cooperation agreement to collaborate on robotics technology [31]. - ZhiYuan Robotics participated in a roundtable discussion on economic trends [22]. - A joint venture was established between Junpu Intelligent and ZhiYuan Robotics to focus on humanoid robots [29]. Event Outlook - A humanoid robot half-marathon is scheduled to take place in Beijing on April 19, 2025, featuring humanoid robots competing alongside human participants [37]. Key Company Profit Forecasts and Investment Ratings - Companies such as Lide Harmony, Mingzhi Electric, and Huichuan Technology are rated as "Outperform" with various earnings per share (EPS) forecasts for 2023 and 2024 [9].

公募基金方面，本期较上一期持股增加的公募基金共计4个，包括交银先进制造混合A、华泰柏瑞富利 混合A、交银均衡成长一年混合A、新华稳健回报灵活配置混合发起，持股增加占比达0.20%。本期较 上一季度持股减少的公募基金共计5个，包括交银启明混合A、汇添富科创板2年定开混合、万家瑞兴 A、交银启信混合发起A、国泰科创板两年定期开放混合，持股减少占比达0.70%。本期较上一季度新 披露的公募基金共计119个，主要包括华泰柏瑞鼎利混合A、鹏华价值优势混合(LOF)、工银中小盘混 合、融通互联网传媒灵活配置混合、国泰君安君得明混合等。本期较上一季未再披露的公募基金共计6 个，主要包括广发利鑫混合A、广发盛锦混合A、财通鼎欣量化选股18个月定开混合、鹏华弘和混合 A、天弘养老目标日期2045五年持有期混合型发起式(FOF)等。 2025年4月12日，优利德(688628.SH)发布2024年年度报告。截至2025年4月11日，共有133个机构投资者 披露持有优利德A股股份，合计持股量达8234.89万股，占优利德总股本的74.00%。其中，前十大机构 投资者包括优利德集团有限公司、中国农业银行股份有限公司-交银施罗德先进制 ...